Polyamine depletion inhibits the autophagic response modulating Trypanosoma cruzi infectivity

María C Vanrell1, Juan A Cueto, Jeremías J Barclay

  • 1Laboratorio de Biología Celular y Molecular; Instituto de Histología y Embriología (IHEM); Universidad Nacional de Cuyo; CONICET; Mendoza, Argentina.

Autophagy
|May 24, 2013
PubMed

Insights

Polyamine depletion using DFMO inhibits host cell autophagy, crucial for Trypanosoma cruzi infection. This suggests DFMO as a potential therapeutic to limit Chagas disease spread.

Area of Science:

  • Cell Biology
  • Parasitology
  • Pharmacology

Background:

  • Autophagy is a cellular recycling process implicated in various physiological and pathological states, including infections by intracellular pathogens.
  • The polyamine spermidine is a known inducer of autophagy.
  • Trypanosoma cruzi, the causative agent of Chagas disease, interacts with host cell autophagy during invasion, and pre-activated autophagy enhances parasite colonization.

Purpose of the Study:

  • To investigate the effect of polyamine depletion on host cell autophagy and Trypanosoma cruzi infectivity.
  • To determine if inhibiting polyamine biosynthesis impacts the autophagic response and parasite colonization.

Main Methods:

  • Depletion of intracellular polyamines using difluoromethylornithine (DFMO), an inhibitor of ornithine decarboxylase.
  • Assessment of autophagy induction via starvation or rapamycin treatment in two cell lines.
  • Quantification of autophagy-related proteins LC3 and ATG5.
  • Evaluation of T. cruzi colonization levels in host cells.

Main Results:

  • DFMO treatment suppressed autophagy induction in response to starvation or rapamycin.
  • Polyamine depletion led to decreased levels of LC3 and ATG5 proteins, essential for autophagosome formation.
  • Inhibition of host cell autophagy by DFMO resulted in impaired T. cruzi colonization.

Conclusions:

  • Polyamines and host cell autophagy facilitate Trypanosoma cruzi infection.
  • DFMO acts as a novel autophagy inhibitor by depleting intracellular polyamines.
  • DFMO, an FDA-approved drug, shows potential for limiting autophagy and parasite spread in Chagas disease and other conditions.